Mark McCormack Selected Research

Mark McCormack Research Topics

6	Epilepsy (Aura) 01/2021 - 08/2012
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 03/2012
3	Hypersensitivity (Allergy) 01/2018 - 03/2011
2	Seizures (Absence Seizure) 01/2023 - 05/2014
2	Hyponatremia 01/2021 - 03/2019
2	Exanthema (Rash) 01/2018 - 03/2011
1	Infantile Spasms (West Syndrome) 01/2023
1	Generalized Epilepsy 01/2020
1	Drug Resistant Epilepsy 12/2019
1	Breast Neoplasms (Breast Cancer) 11/2016
1	Neoplasms (Cancer) 05/2015
1	Delayed Graft Function 05/2015
1	Ataxia (Dyssynergia) 05/2014
1	Intellectual Disability (Idiocy) 05/2014
1	Hypoxia (Hypoxemia) 04/2014
1	Absence Epilepsy (Childhood Absence Epilepsy) 08/2012
1	Idiopathic Generalized Epilepsy 08/2012
1	Juvenile Myoclonic Epilepsy 08/2012
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 03/2011
1	Altitude Sickness (Mountain Sickness) 06/2010

5	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021 - 03/2011
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 01/2018
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2021 - 03/2019
2	SodiumIBA 01/2021 - 03/2019
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2018 - 03/2012
2	Hemoglobins (Hemoglobin)IBA 04/2014 - 06/2010
2	HLA-A Antigens (HLA-A)IBA 03/2012 - 03/2011
1	Vigabatrin FDA Link 01/2023
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Lacosamide FDA Link 12/2019
1	Complement Factor H (Factor H)IBA 01/2018
1	HLA-A31 antigenIBA 01/2018
1	AntigensIBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 11/2016
1	Cytochrome P-450 CYP3AIBA 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2015
1	EnzymesIBA 05/2014
1	DNA (Deoxyribonucleic Acid)IBA 05/2014
1	Erythropoietin FDA Link 04/2014
1	NucleotidesIBA 08/2012
1	Immunoglobulin E (IgE)IBA 08/2012
1	Lamotrigine (Lamictal)FDA LinkGeneric 03/2012
1	HLA-B Antigens (HLA-B)IBA 03/2011